IncretinsVenomsGlucagon-Like Peptide 1Gastric Inhibitory PolypeptideHypoglycemic AgentsReceptors, GlucagonDipeptidyl-Peptidase IV InhibitorsDiabetes Mellitus, Type 2Dipeptidyl Peptidase 4Sulfonylurea CompoundsPeptidesBlood GlucoseMetforminHemoglobin A, GlycosylatedGlucagon-Like PeptidesInsulin, Long-ActingGlucagonInsulinInsulin-Secreting CellsGastric BypassPyrazinesPancreatic alpha-AmylasesTriazolesObesity, MorbidBariatric SurgeryPostprandial PeriodDrug SubstitutionWeight LossAdamantaneInjections, SubcutaneousGlucoseDrug Administration ScheduleGlucose Tolerance TestBody WeightHypoglycemiaDrug Therapy, CombinationPlacebosCandyThiazolidinedionesNauseaTreatment OutcomeDouble-Blind MethodHyperglycemiaCross-Over StudiesAnti-Obesity AgentsPancreatitisPrediabetic StateC-PeptideGastric EmptyingClinical Trials, Phase III as Topic